No black box warning on record for Kanka Triple Action

As of the latest FDA labeling reviewed, Kanka Triple Action (BENZOCAINE AND MENTHOL, UNSPECIFIED FORM) does not carry a black box warning. Standard warnings and precautions still apply — see the full Kanka Triple Action medicine page for the complete safety profile.

Other warnings & precautions

Warnings METHEMOGLOBINEMIA WARNING Use of this product may cause methemoglobinemia, a serious condition that must be treated promptly because it reduces the amount of oxygen carried in blood. This can occur even if you have used this product before. Stop use and seek immediate medical attention if you or a child in your care develops: pale, gray, or blue colored skin (cyanosis) headache rapid hear

No black box warning on record for Kanka Triple Action

Other warnings & precautions

Warnings METHEMOGLOBINEMIA WARNING Use of this product may cause methemoglobinemia, a serious condition that must be treated promptly because it reduces the amount of oxygen carried in blood. This can occur even if you have used this product before. Stop use and seek immediate medical attention if you or a child in your care develops: pale, gray, or blue colored skin (cyanosis) headache rapid hear

Kanka Triple Action Black Box Warning

No black box warning on record for Kanka Triple Action

Other warnings & precautions

Kanka Triple Action Black Box Warning

No black box warning on record for Kanka Triple Action

Other warnings & precautions